Fundraising FoxHorizons Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Endless is an online workspace for content creators that brings AI-assisted tools such as chat, transcript generation, image and video creation, and a social radar into a single platform.
AI & Machine LearningBiotechCreator EconomySaaSTulsa, US
Travis Dahm(Executive Officer)Gary Holland(Executive Officer)Tim Lozott(Executive Officer)
Co-investorsNXTPTranspose Platform ManagementLevel One FundRage CapitalSOSV
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechMedical DevicesWellness & FitnessSacramento, US
David J. Kyle(Executive Officer, Director)inJ. Bruce German(Co-founder)David Mills(Founder)inCarlito Lebrilla(Founder)Daniela Barile(Founder)Samara Freeman(Founder & Executive Director, Regulatory Affairs & Intellectual Property)in
Co-investorsAcre Venture PartnersBow CapitaliSelect FundLongitude CapitalSpruce Capital PartnersXeraya Capital+1 more
Theradaptive develops protein engineering technology that modifies recombinant proteins into material-binding variants for targeted therapeutic delivery, aiming to improve efficacy and reduce off-target effects.
BiotechDeep TechMedical DevicesFrederick, US
Luis Alvarez(Executive Officer, Director)inDavid Stewart(Executive Officer, Director)Ted A. Meyers(Director)George Shanine(Director)David Harrington(Director)Jeffrey Dunn(Director)
Co-investorsMaryland TEDCOTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.